Retinal Cases and Brief Reports 2009
Cystoid macular edema secondary to Paclitaxel (abraxane).
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Veza se sprema u međuspremnik
Ključne riječi
Sažetak
OBJECTIVE
To report a case of cystoid macular edema secondary to systemic paclitaxel.
METHODS
A 58-year-old man with Stage 4 metastatic cutaneous melanoma presented with decreased vision and macular edema while having minimal fluorescein leakage 7 months into a course of paclitaxel chemotherapy. The edema continued to worsen, and vision declined until paclitaxel therapy was discontinued. Six weeks after cessation of paclitaxel, the edema had completely resolved and vision returned to normal.
CONCLUSIONS
Paclitaxel use can result in reversible vision loss associated with angiographically silent macular edema.
